Guidelines on the Management of Atopic Dermatitis ... - Dermatology
Guidelines on the Management of Atopic Dermatitis ... - Dermatology
Guidelines on the Management of Atopic Dermatitis ... - Dermatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 8: Indicati<strong>on</strong>s for referral for specialist dermatological advice<br />
Immediate (same-day) referral:<br />
If eczema herpeticum (KVE) is suspected*<br />
Urgent referral (seen within two weeks):<br />
If <strong>the</strong> AE is severe and has not resp<strong>on</strong>ded to optimal topical <strong>the</strong>rapy after <strong>on</strong>e week<br />
If treatment <strong>of</strong> bacterially infected AE has failed<br />
Routine (n<strong>on</strong>-urgent) referral: If any <strong>of</strong> <strong>the</strong> following apply:<br />
The diagnosis is or has become uncertain.<br />
AE <strong>on</strong> <strong>the</strong> face has not resp<strong>on</strong>ded to appropriate treatment.<br />
The AE is associated with severe and recurrent infecti<strong>on</strong>s.<br />
C<strong>on</strong>tact allergic dermatitis is suspected.<br />
The AE is giving rise to serious social or psychological problems for <strong>the</strong> child, parent,<br />
or carer.<br />
The child, parent, or carer might benefit from specialist advice <strong>on</strong> treatment<br />
applicati<strong>on</strong>.<br />
<strong>Management</strong> has not c<strong>on</strong>trolled <strong>the</strong> AE satisfactorily according to a subjective<br />
assessment by <strong>the</strong> child, parent, or carer.<br />
*KVE=Kaposi‟s varicelliform erupti<strong>on</strong>. KVE refers to viral (HSV/eczema herpeticum,<br />
vaccinia virus / eczema vaccinatum, and Coxsacki virus/eczema coxsackium) infecti<strong>on</strong><br />
superimposed <strong>on</strong> AE. Eczema herpeticum is <strong>the</strong> comm<strong>on</strong>est by far.<br />
Patients, parents(s) or caregivers with corticosteroid phobia (CSP) should be referred. CSP<br />
is frequent and is not an irrati<strong>on</strong>al fear. CSP is <strong>the</strong> term to describe all types <strong>of</strong> fear about<br />
steroid use. In routine clinical practice, it is not unusual for patients to express fear or anxiety<br />
about using topical CS. Topical CSP, a complex phenomen<strong>on</strong>, may lead to poor adherence<br />
and lack <strong>of</strong> resp<strong>on</strong>se.<br />
All patients presenting with erythroderma (dermatitis involving more than 90% <strong>of</strong> BSA), any<br />
acute flare, sp<strong>on</strong>taneous or precipitated by irritati<strong>on</strong> <strong>of</strong> <strong>the</strong> skin, infecti<strong>on</strong>, stress and<br />
inadequate itch c<strong>on</strong>trol need referral.<br />
Complementary / alternative <strong>the</strong>rapies for atopic dermatitis<br />
These treatments can be defined as forms <strong>of</strong> <strong>the</strong>rapy or examinati<strong>on</strong> that have no scientific<br />
basis and for which no effective or diagnostic reliability has been dem<strong>on</strong>strated by scientific<br />
methods. 1 These modalities are becoming more and more popular, 2 which is understandable<br />
when people are faced with an intractable, incurable, highly symptomatic c<strong>on</strong>diti<strong>on</strong> for which<br />
c<strong>on</strong>venti<strong>on</strong>al medicine seem to be <strong>on</strong>ly partially beneficial. Approximately 30% 3 to 42.5% 1 <strong>of</strong><br />
patients with allergies report <strong>the</strong> use <strong>of</strong> complementary treatments in Europe; <strong>the</strong>se tend to<br />
be younger women with a higher educati<strong>on</strong>al background. 3 No reliable figures or records <strong>of</strong><br />
treatment methods exist for <strong>the</strong> treatment <strong>of</strong> atopic dermatitis by African traditi<strong>on</strong>al healers.